We use cookies to give you the best possible experience on our website.

Health and Implementation Workstream

Our aim is to:

  • Reduce the differential between Greater Manchester and the rest of England with respect to mortality attributable to cardiovascular disease - improving outcomes to the level of the upper quartile by 2018, potentially saving 1,000 lives.
  • Systematically measure and reduce medication error – demonstrating reductions in harm attributable to medication error by 2018.  

Cardiovascular Disease Programme

(Figures from the British Heart Foundation, CVD statistics 2014)


We have three areas of focus for our cardiovascular disease work. These are informed by the data from the CVD Intelligence Network and the mandate from Greater Manchester CCGs to priorities these three clinical areas:

  • Atrial Fibrillation (AF)
  • High risk vascular disease population identified via Chronic Kidney Disease (CKD) registers.
  • Familial Hypercholesterolaemia (FH)

Patient Safety Collaborative

In October, NHS England and NHS Improving Quality announced the creation of 15 Patient Safety Collaboratives which are being led by the Academic Health Science Networks.

They will focus on improving safety and empowering patients, carers and staff to highlight, challenge and implement local improvements in patient care. This is because AHSNs provide a unique combination of NHS, academia, third sector and industry partners and work across defined geographical areas.

The collaboratives will bring together patients, healthcare staff and other partners from across the health and care economy to determine their local patient safety priorities and to develop and implement solutions to these problems.

Medicines Optimisation is our focus for the Patient Safety Collaborative. It impacts 15 of the 19 safety topics in the matrix and enables our members to work on their medicines safety priority whilst having a cohesive thread across Greater Manchester allowing us to articulate a shared vision and overarching goal.

Our achievements so far include:

  • Identifying our 10 Q Fellows to support the Health Foundation Q Initiative and help support our patient safety work locally
  • Commissioning AQuA to provide a suite of quality improvement modules. A 6 month Sign up to Safety Learning Network has already been launched and going forward over 240 individual module places are available.
  • Commissioning Haelo to run a one year Break Through Series Collaborative for Medicines Safety, as part of Greater Manchester’s collective ambition to be the safest place to take medicines and achieve a 50% reduction in harm from medication errors in acute and community care by March 2016.

Asset Publisher Asset Publisher

GM-wide Provider Company

Aneet Kapoor, Chair of the Manchester Local Pharmaceutical Committee, discusses new developments in the way pharmacy services are provided in Greater Manchester.

Health Foundation's 'Power of People' films

Our partners for the Q initiative, The Health Foundation, have recently launched the first of five films called the Power of People, which demonstrate what can be achieved when people working in...

Preventing stroke – Ladies first

Jane Macdonald is Associate Director of Nursing and Improvement at Greater Manchester Academic Health Science Network. In this blog for World Stroke Day, she explains why stroke prevention is of...

GM AHSN's Health & Implementation workstream

Donal O’Donoghue is Medical Director at GM AHSN. In this blog he explains the focus of the Health and Implementation workstream.

Building an innovation pipeline for nutrition and hydration

Fifteen Academic Health Science Networks (AHSNs) have been created to deliver a speedier and more effective way to identify, develop and adopt new technologies on behalf of the NHS. They work in...

Patient Safety Congress 2015

Emma Wheatley offers her views on the recent Patient Safety Congress. At the Congress, The case for Patient Safety :Financially, Professionally and ethically was launched.

Medicines Optimisation Roadshow

Read a summary of the highlights of our successful Medicines Optimisation Roadshow held on March 26th here.

Reaction to the Commission on the future of health and social cares in England report.

This week, Professor Donal O’Donoghue, Medical Director of GM AHSN, reacts to the Commission on the future of health and social cares in England report. Set up by the King’s Fund and chaired by...

Health & Implementation Team Health & Implementation Team

Professor Donal O'Donoghue, Medical Director

Professor Donal O'Donoghue was appointed Medical Director for GM AHSN in December 2013. He is a renal physician at Salford Royal NHS Foundation Trust and honorary Professor of Renal Medicine...

Dai Roberts, Programme Development Lead

Dai has recently joined Greater Manchester AHSN as one of three Programme Development Leads within the Health & Implementation team, supporting the design and implementation of large scale...

Cara Afzal, Programme Development Lead

Cara joined GM AHSN in January 2015 as the first Programme Development Lead for Health and Implementation. She is responsible for supporting the design and implementation of large-scale improvement...

Jane Macdonald, Director of Improvement and Nursing, and Patient Safety Lead

Jane was appointed to the role of Associate Director of Nursing and Improvement on 1st April 2014, and in April 2015 became Director of Nursing and Improvement. She brings to the role her...